Financials

  • Market Capitalization 736.64 M
  • Employee 121
  • Founded 2013
  • CEO N/A
  • Website www.solidbio.com
  • Headquarter Delaware, United States
  • FIGI BBG00JN4FXG8
  • Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-2.83
ratio cours/chiffre d'affaires
530.1

Related tickers

#NomPrix24h %7 jours %1M %1 an %Cap Boursière7 Derniers Jours
2587
VSTM
Verastem, Inc. - Common Stock
8.38 USD+3.33%+8.27%+13.86%-3.12%758.92 M USD
2596
LXRX
Lexicon Pharmaceuticals, Inc. - Common Stock
1.68 USD-4.55%-8.20%-15.15%+11.26%747.53 M USD
2606
FDMT
4D Molecular Therapeutics, Inc. - Common Stock
13.33 USD+4.96%-3.82%-2.27%+17.96%736.41 M USD
2609
AVTX
Avalo Therapeutics, Inc. - Common Stock
13.65 USD+1.64%-9.54%-16.92%-1.02%732.05 M USD

Nouvelles